3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Virus Diseases
1
Tumor Virus Infections
1
Squamous Cell Carcinoma of Head and Neck
1
Pharyngeal Diseases
1
Papillomavirus Infections
1
Otorhinolaryngologic Neoplasms
1
Otorhinolaryngologic Diseases
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Head and Neck Neoplasms
1
DNA Virus Infections
1
Carcinoma, Squamous Cell
1
Carcinoma
1
Interventions
Specimen Handling
5
Human Papillomavirus Recombinant Vaccine nonavalent
4
Papillomavirus Vaccines
3
Human Papillomavirus DNA Tests
3
Colposcopy
3
Radiotherapy, Intensity-Modulated
2
Methods
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
Early Intervention, Educational
2
Cisplatin
2
human papillomavirus vaccine, L1 type 16, 18
1
artesunic acid
1
artenimol
1
artemisinin
1
adacel
1
Vaccines
1
Tetanus Toxoid
1
Sodium Chloride
1
Platinum
1
Patient Navigation
1
Nimorazole
1
Mass Screening
1
Interviews as Topic
1
Injections
1
High-Energy Shock Waves
1
Educational Status
1
Diphtheria-Tetanus-acellular Pertussis Vaccines
1
Diphtheria Toxoid
1
Clinical Protocols
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Papillomavirus Infections
×
Nimorazole
×
Clear all
NCT04124198
2025-12-31
QoLATI
Rigshospitalet, Denmark
Phase NA
Active not recruiting
138 enrolled